Semax often comes up alongside other peptides discussed for cognitive effects, and the comparisons floating around online are not always accurate. Semax was previously not offered by telos rx and is now prescribed as a compounded nasal spray after provider review. This article compares it honestly to other nootropic peptides without treating them as interchangeable.
What to know: telos rx now prescribes semax as a compounded nasal spray after an online intake reviewed by a US-licensed provider. A prescription is required, approval is not guaranteed, and semax is not FDA-approved. This article compares its research base and proposed mechanism to other nootropic peptides, so you understand what is genuinely similar and what is not.
What semax is
Semax is a synthetic peptide built from a short fragment of adrenocorticotropic hormone, developed in Russia in the 1980s. It has been studied there primarily around stroke recovery, attention, and neuroprotection.
Semax was previously not available through telos rx while it was under review. In July 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding semax to the list of bulk substances for compounding, pending FDA rulemaking. That recommendation is not regulatory approval.
On October 28, 2026, HHS announced an interim enforcement discretion policy for six peptides (BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500). Under it, HHS does not intend to take enforcement action against state-licensed pharmacies or licensed physicians that compound these peptides with a valid prescription, as long as strict conditions are met: FDA-registered suppliers, lot-level testing, single-ingredient products, specific routes, and adverse event reporting. For semax, the only covered route is intranasal, which matches the telos rx nasal spray. The policy is temporary while FDA decides through rulemaking whether to add these peptides to the list of substances that can be used in compounding. It is not FDA approval, and HHS can revisit it if safety or quality problems arise.
telos rx now prescribes semax as a compounded nasal spray after provider review. You can read how it works on the semax page.
Semax has never been approved by the FDA for any use in the United States, and no finished drug product built around it has been reviewed here.
Why "nootropic peptide" is a loose category
The label nootropic peptide gets applied to a wide range of compounds with different structures, different proposed mechanisms, and very different amounts of supporting research. Grouping them together for marketing convenience can hide real, meaningful differences between them.
Some compounds in this category are peptide fragments of naturally occurring hormones, like semax. Others are entirely synthetic molecules with no natural counterpart. The specific mechanism behind each one matters far more than the shared marketing label they are often sold under.
Semax versus selank
Selank is another peptide developed in the same Russian research tradition as semax, also studied for effects related to mood and anxiety alongside cognitive function. The two share a research lineage and some structural similarity, but they are distinct molecules with separate study bases.
telos rx does not offer selank. It does prescribe semax, as a compounded nasal spray after provider review. Treating them as functionally identical because they share a research tradition overstates what is actually known about each one individually.
Key takeaway: Peptides grouped under "nootropic" often share a category label without sharing a mechanism or an evidence base. Each deserves its own evaluation.
Semax versus growth-hormone-axis peptides
Some peptides discussed for cognitive or energy benefits work through a completely different system: the growth hormone axis. Sermorelin is an example, working by prompting the body's own growth hormone release rather than acting directly on neurotransmitter or neurotrophic pathways the way semax's proposed mechanism does.
These are genuinely different approaches to a loosely related goal. A peptide working through the growth hormone axis is not simply a substitute for one working through a different mechanism. Both can end up in the same "feel sharper" conversation online regardless.
Sermorelin and semax are both offered by telos rx after provider review, which is one practical reason the two get compared even though their underlying biology differs substantially.
Semax versus NAD+ precursor approaches
NAD+ nasal spray works by supporting cellular energy metabolism rather than acting on the specific neurotrophic and attention-related pathways semax has been studied for. The felt effects some people associate with each, like mental clarity or reduced fatigue, can overlap even when the underlying mechanism does not.
This is a common pattern with wellness-adjacent compounds: similar subjective language describing genuinely different biological processes. Understanding the mechanism helps you evaluate a claim rather than just the language used to describe an outcome.
NAD+ nasal spray is currently offered by telos rx and represents a verified, available option for people specifically interested in energy and clarity.
Why availability differs even among similar-sounding peptides
Two peptides can occupy a similar conversational space, like "cognitive support," while sitting in completely different regulatory positions. Availability depends on a specific substance's own regulatory standing, not on how similar it sounds to something already available.
That is why telos rx offered sermorelin and NAD+ nasal spray for some time while semax remained under review, despite all three being discussed in similar terms. Semax was added only after its own review, as a compounded nasal spray, and it is still not FDA-approved.
Semax versus BPC-157
BPC-157 is sometimes mentioned in the same breath as semax because both are peptides with active research interest, but their proposed mechanisms and use cases are quite different. BPC-157 has primarily been studied in the context of tissue repair and gut lining integrity, not cognitive function.
The two get grouped together mostly because they share the word "peptide" and a similar level of online attention, not because they work on the same systems or address the same goal. That kind of grouping is a marketing convenience, not a scientific one.
BPC-157 is currently offered by telos rx, which is a separate fact from anything about its similarity, or lack of similarity, to semax.
Reading claims that lump peptides together
Watch for a single page listing several peptides under one broad claim such as cognitive peptides. It rarely distinguishes each compound's own evidence, which makes for an easier sales pitch than an accurate summary.
When you see peptides grouped this way, look for what specifically is said about each one individually. A page that only makes claims about the group as a whole is a sign the underlying research has not actually been checked compound by compound.
What actually determines whether one peptide can substitute for another
A true substitute would need a similar mechanism and a similar evidence base for your specific outcome. It would also need comparable safety information for how you intend to use it. Sharing a category label satisfies none of those conditions on its own.
This is why a provider conversation matters more than a category comparison. A licensed provider can help match an actual mechanism to an actual goal, rather than relying on how two peptides happen to be marketed alongside each other.
What this means for comparison shopping
If you are comparing peptides based on online descriptions, be cautious of language treating a group as interchangeable simply because they serve a similar rough purpose. Mechanism, evidence base, and regulatory status are each independent variables.
A peptide with a stronger evidence base is not automatically the same as one with a longer marketing history. A peptide that is currently available is not automatically the best fit for your specific goal. Each of these questions deserves separate consideration rather than a single blended judgment.
Why the same peptide can be described very differently by different sellers
The same underlying research on semax can be summarized in noticeably different ways depending on who is writing about it. A seller motivated to make a sale tends to choose the most favorable framing available, while a neutral source is more likely to note limitations alongside findings.
This is not necessarily dishonesty in a legal sense. It is simply how emphasis and framing work, and it applies to comparisons between peptides just as much as to descriptions of a single one. A comparison written by a seller of one product will rarely make the competing option look equally good, even when the underlying evidence would support it.
Reading multiple independent sources, including neutral research databases rather than only product pages, gives you a more balanced picture than any single comparison article, including this one, can provide on its own.
Which is right for you
If your interest in semax is an interest in feeling sharper or more capable day to day, you can start a semax intake. A US-licensed provider reviews it, and if semax is appropriate, your provider sets the dose and schedule for the compounded nasal spray. Approval is not guaranteed.
telos rx also offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin, each through a licensed intake and a partner compounding pharmacy. NAD+ nasal spray, as low as $99 a month, is another option for energy and mental clarity goals.
Frequently Asked Questions
Is semax the same as selank?
No. They share a Russian research tradition and some structural similarity, but they are distinct peptides with separate study bases. telos rx prescribes semax as a compounded nasal spray after provider review; it does not offer selank.
Does sermorelin work the same way as semax?
No. Sermorelin works through the growth hormone axis, while semax's proposed mechanism involves neurotrophic and attention-related pathways. They are different approaches, not interchangeable options.
Why did telos rx offer sermorelin and NAD+ before semax?
Each substance has its own regulatory standing. Semax was previously under review; after the July 2026 committee recommendation and telos rx's own review, it is now prescribed as a compounded nasal spray. An interim HHS enforcement discretion policy announced October 28, 2026 covers intranasal semax while FDA rulemaking continues. It is not FDA approval.
Is semax FDA-approved?
No. Semax has never gone through FDA approval for any use in the United States.
Should I assume similar peptides have similar evidence behind them?
No. Mechanism, evidence base, and regulatory status vary independently between peptides, even when they get grouped under a shared marketing label.
What can I start today if I want cognitive or energy support?
telos rx prescribes semax as a compounded nasal spray after provider review, and also offers NAD+ nasal spray, BPC-157, PT-141, and sermorelin, each through a licensed intake and a partner compounding pharmacy.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved, and semax is not FDA-approved. Prescription required; approval is not guaranteed. This article is general information, not medical advice, and does not replace guidance from your own provider. Individual circumstances vary, and approval for any protocol is subject to evaluation by a licensed provider.
For research background on semax, see this peer-reviewed study archived by the National Institutes of Health. For how compounded medications are regulated in the United States, see the FDA's overview of drug compounding.